Opportunity Information: Apply for W81XWH 15 RTR CTA
Apply for W81XWH 15 RTR CTA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD FY15 Reconstructive Transplant Research (RTR) Clinical Trial Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on Jul 23, 2015 and posted on Jul 23, 2015.
- Applicants must submit their applications by Dec 1, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $6,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD FY15 Reconstructive Transplant Research (RTR) Clinical Trial Award (Funding Opportunity Number W81XWH-15-RTR-CTA) is a U.S. Department of Defense funding opportunity designed specifically to support human clinical trials in reconstructive transplantation research, with an emphasis on outcomes that matter to injured Service members and Veterans. The solicitation was issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate, which manages Defense Health Program research dollars under the Research, Development, Test, and Evaluation appropriation. While the money originates within DoD health research priorities, the program and awards are administered through the Congressionally Directed Medical Research Programs (CDMRP), with strategic guidance from Joint Program Committee 8 (Clinical and Rehabilitative Medicine Research Program).
This award mechanism was offered for the first time in FY15 and is explicitly intended to fund clinical trials that could meaningfully improve function, wellness, and overall quality of life, not only for patients but also for caregivers and families, and potentially the broader public. The program frames its mission around reconstructive transplantation and vascularized composite allotransplantation (VCA) related challenges, and applicants are required to align their proposed work with at least one of the program’s stated Focus Areas. Those Focus Areas include immune system regulation (for example, improving immunosuppression strategies or immune tolerance approaches), improved access to reconstructive transplantation (which can include removing logistical, clinical, or systems barriers), reconstructive transplantation rehabilitation (optimizing recovery and functional outcomes), graft surveillance and clinical monitoring (methods to detect rejection, complications, and performance issues earlier and more reliably), and psychosocial issues associated with VCA (mental health, adjustment, adherence, identity, social reintegration, and related caregiver/family impacts).
A central requirement of the RTR Clinical Trial Award is that funds must be used to conduct a clinical trial, and not preclinical or purely laboratory research. The announcement uses a standard definition of a clinical trial: the prospective enrollment (accrual) of human subjects in which an intervention is tested for a measurable outcome. The intervention can be broad, including devices, drugs, biologics, surgical procedures, rehabilitation modalities, behavioral interventions, or other approaches, but it must be evaluated through outcomes that speak to exploratory findings, safety, effectiveness, and/or efficacy. In other words, the research has to involve direct interaction with human participants and assess the real-world effects of the intervention on those participants. Investigators who only have preclinical aims are directed to consider other RTR funding mechanisms rather than this one.
From an administrative and funding standpoint, the opportunity was categorized as discretionary and could be made as a cooperative agreement or grant, under the science and technology/research and development activity area. The listing is associated with CFDA 12.420 (Military Medical Research and Development). The total estimated funding for the competition was $6,000,000, with an expectation of making about two awards, and it did not require cost sharing or matching. Eligibility was described as unrestricted, meaning it was broadly open to a wide range of applicant organization types, subject to any additional eligibility details contained in the full announcement.
Key dates included a posted and creation date of July 23, 2015, and an application closing date of December 1, 2015 (with an archive date of December 31, 2015). For applicant support, CDMRP provided a help desk contact (help@cdmrp.org and 301-682-5507) for issues accessing the full announcement.
FY15 DoD Reconstructive Transplant Research (RTR) Clinical Trial Award (W81XWH-15-RTR-CTA) FAQs
What is this funding opportunity?
The DoD FY15 Reconstructive Transplant Research (RTR) Clinical Trial Award (Funding Opportunity Number W81XWH-15-RTR-CTA) is a U.S. Department of Defense grant opportunity intended to support human clinical trials in reconstructive transplantation research, with emphasis on outcomes that matter to injured Service members and Veterans.
Who issued and administers this opportunity?
The solicitation was issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate. The program and awards are administered through the Congressionally Directed Medical Research Programs (CDMRP), with strategic guidance from Joint Program Committee 8 (Clinical and Rehabilitative Medicine Research Program).
What is the overall purpose of the RTR Clinical Trial Award?
The purpose is to fund clinical trials that could meaningfully improve function, wellness, and overall quality of life for patients, as well as caregivers and families, and potentially benefit the broader public.
Is this award mechanism new?
Yes. This award mechanism was offered for the first time in FY15.
What research area is this opportunity focused on?
The program is centered on reconstructive transplantation and vascularized composite allotransplantation (VCA) related challenges.
Do proposed projects need to align to specific Focus Areas?
Yes. Applicants are required to align their proposed work with at least one of the program's stated Focus Areas.
What are the program Focus Areas?
The Focus Areas described in the opportunity include:
- Immune system regulation (for example, improving immunosuppression strategies or immune tolerance approaches)
- Improved access to reconstructive transplantation (including removal of logistical, clinical, or systems barriers)
- Reconstructive transplantation rehabilitation (optimizing recovery and functional outcomes)
- Graft surveillance and clinical monitoring (methods to detect rejection, complications, and performance issues earlier and more reliably)
- Psychosocial issues associated with VCA (mental health, adjustment, adherence, identity, social reintegration, and caregiver/family impacts)
Is a clinical trial required to use this funding mechanism?
Yes. A central requirement is that funds must be used to conduct a clinical trial, not preclinical or purely laboratory research.
How does the announcement define a clinical trial?
The announcement uses a standard definition: a clinical trial involves prospective enrollment (accrual) of human subjects in which an intervention is tested for a measurable outcome.
What kinds of interventions can be tested in the clinical trial?
The intervention can be broad and may include devices, drugs, biologics, surgical procedures, rehabilitation modalities, behavioral interventions, or other approaches, as long as it is tested in humans for measurable outcomes.
What types of outcomes should the trial measure?
The trial should evaluate outcomes that speak to exploratory findings, safety, effectiveness, and/or efficacy, and the opportunity emphasizes outcomes that matter to injured Service members and Veterans.
Does the project need to involve direct interaction with human participants?
Yes. The research must involve direct interaction with human participants and assess real-world effects of the intervention on those participants.
Are preclinical-only projects eligible under this award?
No. Investigators with only preclinical aims are directed to consider other RTR funding mechanisms rather than this one.
What type of award is this (grant vs cooperative agreement)?
From an administrative standpoint, awards could be made as a cooperative agreement or a grant.
How is this opportunity categorized?
The opportunity was categorized as discretionary and falls under the science and technology/research and development activity area.
What is the CFDA number associated with this opportunity?
The listing is associated with CFDA 12.420 (Military Medical Research and Development).
How much total funding was estimated for this competition?
The total estimated funding for the competition was $6,000,000.
How many awards were expected?
The opportunity expected to make about two awards.
Is cost sharing or matching required?
No. The opportunity did not require cost sharing or matching.
Who is eligible to apply?
Eligibility was described as unrestricted, meaning it was broadly open to a wide range of applicant organization types, subject to any additional eligibility details contained in the full announcement.
When was the opportunity posted?
The posted and creation date was July 23, 2015.
What was the application deadline?
The application closing date was December 1, 2015.
When was the archive date?
The archive date was December 31, 2015.
Where can applicants get help accessing the full announcement?
For issues accessing the full announcement, CDMRP provided a help desk at help@cdmrp.org and 301-682-5507.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: Research Grants (Generic)
Previous opportunity: To promote and engage in the protection and preservation of the Trail of Tears National Historic Trai.
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 15 RTR CTA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 15 RTR CTA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD FY15 Reconstructive Transplant Research (RTR) Idea Discovery Award Apply for W81XWH 15 RTR IDA Funding Number: W81XWH 15 RTR IDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD FY15 Reconstructive Transplant Research (RTR) Translational Research Award Apply for W81XWH 15 RTR TRA Funding Number: W81XWH 15 RTR TRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Department of Defense Explosive Ordnance Disposal Science and Technology Apply for N00014 15 R SN13 Funding Number: N00014 15 R SN13 Agency: Office of Naval Research Category: Science and Technology and other Research and Development Funding Amount: $700,000 |
| DoD Breast Cancer Breakthrough Award Level 3 Award Apply for W81XWH 15 BCRP BREAKTHROUGH2 FL3 Funding Number: W81XWH 15 BCRP BREAKTHROUGH2 FL3 Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY15 Supplemental for Evaluation of Wheel/Rail Contact Mechanics, VT Apply for FR RRD 15 015 Funding Number: FR RRD 15 015 Agency: DOT/Federal Railroad Administration Category: Science and Technology and other Research and Development Funding Amount: $231,000 |
| CISE Research Infrastructure Apply for 15 590 Funding Number: 15 590 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $2,500,000 |
| Biotechnology and Biochemical Engineering Apply for PD 15 1491 Funding Number: PD 15 1491 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $600,000 |
| Nano Biosensing Apply for PD 15 7909 Funding Number: PD 15 7909 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $600,000 |
| Nano Bio Phenomena and Processes in the Environment Apply for PD 15 1179 Funding Number: PD 15 1179 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Environmental Engineering Apply for PD 15 1440 Funding Number: PD 15 1440 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Fluid Dynamics Apply for PD 15 1443 Funding Number: PD 15 1443 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| General Age Related Disabilities Engineering Apply for PD 15 5342 Funding Number: PD 15 5342 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Biomedical Engineering Apply for PD 15 5345 Funding Number: PD 15 5345 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $600,000 |
| Chemical and Biological Separations Apply for PD 15 1417 Funding Number: PD 15 1417 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Particulate and Multiphase Processes Apply for PD 15 1415 Funding Number: PD 15 1415 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Combustion and Fire Systems Apply for PD 15 1407 Funding Number: PD 15 1407 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Thermal Transport Processes Apply for PD 15 1406 Funding Number: PD 15 1406 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Biophotonics Apply for PD 15 7236 Funding Number: PD 15 7236 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $600,000 |
| Catalysis and Biocatalysis Apply for PD 15 1401 Funding Number: PD 15 1401 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Environmental Sustainability Apply for PD 15 7643 Funding Number: PD 15 7643 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 15 RTR CTA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
